Advertisement
Advertisement

CSTL

CSTL logo

Castle Biosciences, Inc. Common Stock

21.12
USD
Sponsored
+0.87
+4.30%
Jun 18, 16:00 UTC -4
Closed
exchange

After-Market

21.08

-0.04
-0.19%

Castle Biosciences, Inc. Common Stock Profile

About

Castle Biosciences Inc. is a commercial-stage dermatological cancer company. It is focused on providing physicians and patients, clinically actionable genomic information. Castle Biosciences Inc. is based in Texas, United States.

Info & Links

CEO

Derek J. Maetzold

Headquarters

1500 W. Parkwood Ave, Suite 400
Friendswood, TX 77546, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://castlebiosciences.com

Auditor

KPMG LLP

Share holders

73

Employees

883

Castle Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

639.36M

Enterprise Value

585.95M

Enterprise Value/EBITDA(ttm)

-27.14

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.06

Price to Book(mrq)

1.45

Price to Cash(ytd)

21.05

Profitability

Gross Margin(ttm)

79.34%

Operating Margin(ttm)

-1.18%

Profit Margin(ttm)

-6.85%

Return on Equity(ttm)

-0.89%

Return on Invested Capital(ttm)

-5.36%

Return on Assets(ttm)

-0.74%

Income Statement

Revenue(ttm)

339.92M

Revenue Per Share(ttm)

11.21

Gross Profit(ttm)

264.74M

EBITDA(ttm)3

-21.59M

Net Income Available to Common(ttm)

-12.83M

Diluted EPS(ttm)

-0.85

Share Statistics

Beta (5Y Monthly)

1.18

52-Week Change

11.69%

S&P 500 52-Week Change

24.49%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

30.33M

Dividend Yield

0.00%

Float4

27.80M

% Held by Insiders

6.50%

% Held by Institutions

92.60%

Balance Sheet

Total Cash(mrq)

261.69M

Total Cash Per Share(mrq)

8.63

Total Debt(mrq)

10.35M

Total Debt/Equity(mrq)

2.20%

Current Ratio(mrq)

5.26%

Quick Ratio(mrq)

5.11%

Book Value Per Share(mrq)

15.86

Cash Flow

Operating Cash Flow Per Share(ytd)

2.22

Free Cash Flow(ytd)

28.37M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement